Nafise Masoumi is a senior associate at RiverVest Venture Partners, where she focuses on deal sourcing, due diligence, and analysis of prospective investments and provides operational support for RiverVest’s portfolio companies.
It is an honor to work alongside such a disciplined and collaborative team and a privilege to contribute to RiverVest's mission of transforming cutting-edge science into life-changing therapies for patients."
Nafise Masoumi, Ph.D., joined RiverVest in 2024 as a senior associate based in the San Diego office, bringing extensive MedTech and biopharma experience, both in academia and the investment industry, to support strong decision-making and company oversight.
Before joining RiverVest, Nafise worked at Novo Holdings Venture Investments, where she engaged in discovery and due diligence for early- and late-stage biotech companies. Prior to Novo, Nafise worked at Takeda and Boston Consulting Group. Earlier in her career, Nafise completed fellowships at Flagship Pioneering and the Wyss Institute at Harvard.
Nafise earned a Ph.D. in Biochemical Engineering at the Harvard-MIT Program in Health Sciences & Technology (HST) and Penn State. She completed her postdoctoral fellowship in Robert Langer’s lab at MIT and at the Department of Cardiac Surgery at Boston Children’s Hospital, Harvard Medical School. Nafise holds MSc and BSc degrees in Chemical Engineering from Sharif University of Technology in Iran and was a visiting scholar at the Institute of Biomedical Engineering (IBME) at Oxford University, where she analyzed energy metabolism in the brain. Nafise has co-authored 21 peer-reviewed journal publications.